Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1997 1
1998 1
1999 2
2000 1
2001 3
2002 5
2003 3
2004 4
2005 12
2006 12
2007 17
2008 25
2009 26
2010 18
2011 18
2012 17
2013 14
2014 25
2015 23
2016 20
2017 8
2018 12
2019 11
2020 11
2021 11
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

282 results
Results by year
Filters applied: . Clear all
Page 1
Immunological Aspects of Approved MS Therapeutics.
Rommer PS, Milo R, Han MH, Satyanarayan S, Sellner J, Hauer L, Illes Z, Warnke C, Laurent S, Weber MS, Zhang Y, Stuve O. Rommer PS, et al. Among authors: stuve o. Front Immunol. 2019 Jul 11;10:1564. doi: 10.3389/fimmu.2019.01564. eCollection 2019. Front Immunol. 2019. PMID: 31354720 Free PMC article. Review.
Defining the clinical course of multiple sclerosis: the 2013 revisions.
Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B Jr, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O'Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH. Lublin FD, et al. Among authors: stuve o. Neurology. 2014 Jul 15;83(3):278-86. doi: 10.1212/WNL.0000000000000560. Epub 2014 May 28. Neurology. 2014. PMID: 24871874 Free PMC article.
Removal Notice.
Deason K, Miller-Little WA, Stüve O. Deason K, et al. Among authors: stuve o. Mult Scler. 2017 Apr;23(5):NP1. doi: 10.1177/1352458515574150. Epub 2016 Jul 11. Mult Scler. 2017. PMID: 26014603 Free PMC article. No abstract available.
Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study.
Selmaj K, Li DK, Hartung HP, Hemmer B, Kappos L, Freedman MS, Stüve O, Rieckmann P, Montalban X, Ziemssen T, Auberson LZ, Pohlmann H, Mercier F, Dahlke F, Wallström E. Selmaj K, et al. Among authors: stuve o. Lancet Neurol. 2013 Aug;12(8):756-67. doi: 10.1016/S1474-4422(13)70102-9. Epub 2013 Jun 11. Lancet Neurol. 2013. PMID: 23764350 Clinical Trial.
Sodium Phenylbutyrate-Taurursodiol for ALS.
Herz J, Stüve O. Herz J, et al. Among authors: stuve o. N Engl J Med. 2020 Dec 3;383(23):2294. doi: 10.1056/NEJMc2030710. N Engl J Med. 2020. PMID: 33264554 No abstract available.
Natalizumab: Perspectives from the Bench to Bedside.
Shirani A, Stüve O. Shirani A, et al. Among authors: stuve o. Cold Spring Harb Perspect Med. 2018 Dec 3;8(12):a029066. doi: 10.1101/cshperspect.a029066. Cold Spring Harb Perspect Med. 2018. PMID: 29500304 Free PMC article. Review.
Immunopathogenesis of neuromyelitis optica.
Levy M, Wildemann B, Jarius S, Orellano B, Sasidharan S, Weber MS, Stuve O. Levy M, et al. Among authors: stuve o. Adv Immunol. 2014;121:213-42. doi: 10.1016/B978-0-12-800100-4.00006-4. Adv Immunol. 2014. PMID: 24388217 Review.
Clinical trials in multiple sclerosis: milestones.
Zhang Y, Salter A, Cutter G, Stuve O. Zhang Y, et al. Among authors: stuve o. Ther Adv Neurol Disord. 2018 Jul 9;11:1756286418785499. doi: 10.1177/1756286418785499. eCollection 2018. Ther Adv Neurol Disord. 2018. PMID: 30034537 Free PMC article. Review.
Managing Disability in Progressive Multiple Sclerosis.
Dubey D, Sguigna P, Stüve O. Dubey D, et al. Among authors: stuve o. Curr Treat Options Neurol. 2016 Jun;18(6):27. doi: 10.1007/s11940-016-0412-7. Curr Treat Options Neurol. 2016. PMID: 27089873 Review.
B cell-directed therapies in multiple sclerosis.
Gasperi C, Stüve O, Hemmer B. Gasperi C, et al. Among authors: stuve o. Neurodegener Dis Manag. 2016;6(1):37-47. doi: 10.2217/nmt.15.67. Neurodegener Dis Manag. 2016. PMID: 26782316 Review.
282 results